[1] Jemal A, Bray F, Center M M, et al. Global cancer statistics[J]. CA: A Cancer Journal for Clinicians, 2011, 61(2): 69-90.
[2] Srivatanakul P, Sriplung H, Deerasamee S. Epidemiology of liver cancer: An over view[J]. Asian Pacific Journal of Cancer Prevention, 2004, 5(2): 118-125.
[3] 上海医药.《2012中国肿瘤登记年报》发表[J]. 上海医药, 2013, 34(4): 7. Shanghai Medical & Pharmaceutical Journal. The 2012 annual report of China tumor published[J] Shanghai Medical & Pharmaceutical Journal, 2013, 34(4): 7.
[4] 哈木拉提·吾甫尔. 维吾尔医气质、体液论及其现代研究[M]. 乌鲁木 齐: 新疆科学技术出版社, 2003: 34-37, 131-133. Upur Halmurat. Modern research of Uighur medicine temperament body fluid theory[M]. Urumq: Xinjiang Science Technology Publishing Company, 2003: 34-37, 131-133.
[5] 玉苏甫·吐尔逊, 斯坎德尔·白克力, 哈木拉提·吾甫尔等. 异常黑胆质 型肝癌病证模型肝硬化期的肝脏形态学研究[J]. 科技导报, 2010, 28 (24): 82-88. Tursun Yusupjan, Bakri Iskandar, Upur Halmurat, et al. Morphological study on hepatic tissue in hepatocirrhosis phase of hepatocarcinoma carrying abnormal Savda model[J]. Science & Technology Review, 2010, 28(24): 82-88.
[6] Okubo H, Moriyama M, Tanaka N, et al. Detection of serum and intrahepatic hepatocyte growthfactor during DEN-induced carcinogenesis in the rat[J]. Hepatology Research, 2002, 24(4): 385-394.
[7] Sengupta D, Chowdhury K D, Sarkar A, et al. Berberine and S allyl cysteine mediatedamelioration of DEN+CCl4 induced hepatocarcinoma[J]. Biochimica et Biophysica Acta (BBA): General Subjects, 2013, 1840 (1): 219-244.
[8] Leng T, Liu N, Dai Y, et al. Dissection of DEN-induced platelet proteome changes reveals theprogressively dys-regulated pathways indicative of hepatocarcinogenesis[J]. Journal of Proteome Research, 2010, 9(12): 6207-6219.
[9] Nagahara T, Okano J, Fujise Y, et al. Preventive effect of JTE-522, a selectivecyclooxygenase-2 inhibitor, on DEN-induced hepatocarcinogenesis in rats[J]. Medicine Science Entry for Biomedicine & Pharmacotherapy, 2010, 64(5): 319-326.
[10] Sehrawat A, Sultana S. Evaluation of possible mechanisms of protective role of Tamarixgallica against DEN initiated and 2-AAF promoted hepatocarcinogenesis in male Wistar rats[J]. Life Sciences, 2006, 79 (15): 1456-1465.
[11] 张志敏, 王阁, 陈川, 等. 改进性DEN诱发大鼠肝癌模型的建立与病理形态学研究[J]. 第三军医大学学报, 2007, 29(12): 1164-1167. Zhang Zhimin, Wang Ge, Chen Chuan, et al. Pathologic andmorphologic study on modified DEN-induced hepatocarcinoma model in rats[J]. Journal of Third Military Medical University, 2007, 29 (12): 1164-1167.
[12] 程延安, 袁利超, 党双锁, 等. 间断小剂量DEN诱发大鼠肝癌模型研 究[J]. 中华肿瘤防治杂志, 2005, 12(11): 806-808. Cheng Yan'an, Yuan Lichao, Dang Shuangsuo, et al. Research of rat hepatocarcinogenesis model induced by low doses of DEN interruptedly [J]. Chinese Journal of Cancer Prevention and Treatment, 2005, 12(11): 806-808.
[13] 金星林, 千昌石, 杜希臣, 等. 改良法建立大鼠原发性肝癌变模型与 病理形态学研究[J].中国现代医学杂志, 2009, 19(17): 2593-2595. Jin Xinglin, Qian Changshi, Du Xichen, et al. Pathologic and morphologic study on modified DEN-induced hepatocarcinoma model in rats[J]. China Journal of Modern Medicine, 2009, 19(17): 2593-2595.
[14] 吴清洪, 顾为望, 程天明, 等. 二乙基亚硝胺诱发大鼠肝癌模型的建 立及其应用[J]. 动物医学进展, 2001, 22(3): 50-51. Wu Qinghong, Gu Weiwang, Cheng Tianming, et al. Establishment of a rat model carrying hepatocellular carcinoma by DENA induced and its application[J]. Progress in Veterinary Medicine, 2001, 22(3): 50-51.
[15] 玉苏甫·吐尔逊, 哈木拉提·吾甫尔, 阿不都卡德尔·库尔班, 等. 二乙 基亚硝胺诱发大鼠肝硬化模型的建立及病理学研究[J]. 新疆医科大 学学报, 2011, 34(3): 261-264. Tursun Yusup, Upur Halmurat, Kurba Abdukadir, et al. Pathologic study on DEN-induced hepatocirrhosis model in rats[J]. Journal of Xinjiang Medical University, 2011, 34(3): 261-264.
[16] 汤靓. DEN诱导大鼠肝癌模型的代谢组学研究[D]. 上海: 第二军医 大学, 2010. Tang Liang. Metabonomic investigations of DEN induced hepatocellular carcinoma in SD rat[D]. Shanghai: The Second Military Medical University, 2010.
[17] 努尔买买提·艾买提, 哈木拉提·吾甫尔, 阿迪力. 异常黑胆质载体动 物模型免疫学本质的研究[J] . 中国中医基础医学杂志, 2006, 12 (12): 903-907. Ammat Nurmammat, Upur Halmurat, Adili, et al. Study on the abnormal savda syndrome animal model of immunological nature[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2006, 12(12): 903-907.
[18] 张莉, 哈木拉提·吾甫尔, 胡尔西旦·尼可孜, 等. 异常黑胆质载体动 物肿瘤模型的建立及其神经内分泌免疫指标的改变[J]. 国际病理科 学与临床杂志, 2007, 27(5): 376-381. Zhang Li, Upur Hmurat, Niyazi Huerxidan, et al. Establishment of abnormal savda syndrome tumor model and the alteration of its neuroendocrine-immune network[J]. International Journal of Pathology and Clinical Medicine, 2007, 27(5): 376-381.
[19] 张有辉, 玉苏甫·吐尔逊, 哈木拉提·吾甫尔, 等. 异常黑胆质型肝癌 病证模型肝硬化期免疫、内分泌紊乱状态[J]. 科技导报, 2010, 28 (11):39-41. Zhang Youhui, Tursun Yusup, Upur Halmurat, et al. Disordered immune-endocrin network in hepatocirrhosis phase of hepatocarcinoma of carrying abnormal savda model[J]. Science & Technology Review, 2010, 28(11): 39-41.
[20] 张莉, 哈木拉提·吾甫尔, 玛依努尔·艾力, 等. 恶性肿瘤的维医分型 及其神经内分泌免疫网络紊乱研究[J]. 中国中医基础医学杂志, 2008, 14(2): 119-121. Zhang Li, Upur Halmurat, Aili Mayinuer, et al. Type and neuroendocrine immune network disorder of malignant tumor in Uygur Medicine[J]. Chinese Journal of Basic Medicine in Traditional Chinese Medicine, 2008, 14(2): 119-121.
[21] 买买提·努尔艾合提, 厉蓓, 董竞成. 维吾尔族传统医学异常黑胆质 证的研究概况[J]. 中国民族医药杂志, 2013(2): 44-49. Nurahmat Mammat, Li Bei, Dong Jingcheng. Survey of studies on abnormal Savda syndrome in traditional Uighur medicine[J]. Journal of Medicine & Pharmacy of Chinese Minorities, 2013(2): 44-49.
